The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance. Global Scientific Review, [S. l.], v. 48, p. 42–45, 2026. Disponível em: https://scienticreview.com/index.php/gsr/article/view/602. Acesso em: 6 may. 2026.